AI Medica
Techstars '25Alabaster, US · Founded 2020 · Utah corporation · 1 known investors
AI Medica provides evidence-based EHR automation software for physicians to optimize patient coding, documentation, and reimbursement. The platform integrates with existing EHR systems to support value-based care delivery and improve clinical outcomes.
AI & Machine LearningDigital HealthHealthtechSaaS
Founders & leadership
AI Medica was founded in 2020 by Adam Robison, MD.
AR
Adam Robison, MDinFounder
SP
Spencer PattersonNamed on SEC filing
AR
Adam RobisonNamed on SEC filing
JR
Jordon RitchieNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$100K disclosed across 1 of 3 rounds · 2021–2023
▶$1MofferedSep 2023 · Other Health CareRule 506(b)
▶$1MofferedSep 2023 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Adam RobisonExecutive Officer, Director
- Jordon RitchieExecutive Officer, Director
- Bryan RitchieDirector
- Offering amount
- $1M
- Incorporated
- Corporation, Utah, 2020
- Federal exemptions
- 06b
▶$2MofferedMay 2022 · Other Health CareRule 506(b)
▶$2MofferedMay 2022 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bryan RitchieDirector
- Adam RobisonExecutive Officer, Director
- Jordon RitchieExecutive Officer, Director
- Offering amount
- $2M
- Incorporated
- Corporation, Utah, 2020
- Federal exemptions
- 06b
▶$100KraisedSep 2021 · 1 investors · Other Health CareRule 506(b)
▶$100KraisedSep 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Spencer PattersonDirector
- Adam RobisonExecutive Officer, Director
- Jordon RitchieExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $100K
- First sale
- Aug 2021
- Incorporated
- Corporation, Utah, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Infermedica5 shared keywordsInfermedica develops an AI-powered healthcare platform for symptom assessment, triage, and patient intake that integrates into clinical workflows to improve patient access to care. The platform serves healthcare providers and patients globally across 35 countries, supporting primary care and clinical decision-making across 26 languages.
DiaMedica Therapeutics4 shared keywordsDiaMedica Therapeutics develops therapies aimed at reducing ischemia in patients with serious vascular diseases, with an initial focus on preeclampsia, fetal growth restriction, and acute ischemic stroke. It is a clinical-stage biopharmaceutical company working on treatments for ischemic disorders.
Companies competing with AI Medica for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does AI Medica do?
- AI Medica provides evidence-based EHR automation software for physicians to optimize patient coding, documentation, and reimbursement. The platform integrates with existing EHR systems to support value-based care delivery and improve clinical outcomes.
- Who founded AI Medica?
- AI Medica was founded by Adam Robison, MD in 2020.
- Who are AI Medica's investors?
- AI Medica's investors include Techstars.
- How much funding has AI Medica raised?
- AI Medica has disclosed $100K raised across 1 of its 3 known rounds.
- Where is AI Medica headquartered?
- AI Medica is headquartered in Alabaster, US.